Skip to main content
. 2023 Sep 12;18:60. doi: 10.1186/s13024-023-00647-y

Fig. 3.

Fig. 3

Cross-sectional correlation analyses between 11C-DED PET binding and plasma GFAP levels. (A-B) Scatterplots evaluating the relationship between 11C-DED PET binding and plasma GFAP levels in carriers of ADAD mutations and patients with sporadic Alzheimer’s disease for composite temporal ROIs, and (C) surface maps illustrating in colour the cortical ROIs with a significant cross-sectional association between 11C-DED PET binding and plasma GFAP. The Spearman’s correlation coefficient (rho), the p and power values are shown. NC: non-carriers; pMC: presymptomatic mutation carriers; sMC: symptomatic mutation carriers; MCI+: MCI with a positive amyloid-β PET scan; AD: Alzheimer’s disease dementia